102 related articles for article (PubMed ID: 6405570)
1. Impaired prolactin response to arginine infusion and insulin hypoglycaemia in chronic renal failure.
Schmitz O; Møller J
Acta Endocrinol (Copenh); 1983 Apr; 102(4):486-91. PubMed ID: 6405570
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the regulation of prolactin in patients with chronic renal failure.
Ramirez G; O'Neill WM; Bloomer HA; Jubiz W
J Clin Endocrinol Metab; 1977 Oct; 45(4):658-61. PubMed ID: 410821
[TBL] [Abstract][Full Text] [Related]
3. Dynamic evaluation of growth hormone (GH) and prolactin (hPRL) secretion in active acromegaly with high and low GH output.
Tolis G; Kovacs L; Friesen H; Martin JB
Acta Endocrinol (Copenh); 1975 Feb; 78(2):251-7. PubMed ID: 803748
[TBL] [Abstract][Full Text] [Related]
4. Decreased prolactin secretion in childhood obesity.
AvRuskin TW; Pillai S; Kasi K; Juan C; Kleinberg DL
J Pediatr; 1985 Mar; 106(3):373-8. PubMed ID: 3919166
[TBL] [Abstract][Full Text] [Related]
5. Prolactin responses to vasoactive intestinal polypeptide and thyrotropin releasing hormone in chronic renal failure.
Arnaout MA; Hamzeh YS; Ajlouni KM
Acta Endocrinol (Copenh); 1991 Dec; 125(6):651-6. PubMed ID: 1789061
[TBL] [Abstract][Full Text] [Related]
6. Impact of euglycaemia and hyperglycaemia on the release of growth hormone and prolactin in type II-diabetics.
Vierhapper H; Bratusch-Marrain P; Waldhäusl W; Nowotny P; Panzer S
Horm Metab Res; 1983 Jan; 15(1):24-9. PubMed ID: 6403444
[TBL] [Abstract][Full Text] [Related]
7. Prolactin, Growth hormone, thyrotropin, insulin, C-peptide, glucose tolerance and pituitary-gonadal axis in patients with compensated renal failure.
Schernthaner G; Stummvoll HK; Ludwig H; Spona J
Proc Eur Dial Transplant Assoc; 1979; 16():703-5. PubMed ID: 121463
[No Abstract] [Full Text] [Related]
8. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
Kamal TJ; Molitch ME
Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473
[TBL] [Abstract][Full Text] [Related]
9. Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man.
Röjdmark S; Andersson DE; Sundblad L
J Clin Endocrinol Metab; 1981 Sep; 53(3):594-8. PubMed ID: 6790560
[TBL] [Abstract][Full Text] [Related]
10. Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.
Iglesias P; Selgas R; Méndez J; Fernández-Reyes MJ; Bajo MA; Aguilera A; Díez JJ
Nephrol Dial Transplant; 2000 Jun; 15(6):856-61. PubMed ID: 10831641
[TBL] [Abstract][Full Text] [Related]
11. [The sella turcica and pituitary function in congenital hypothyroidism due to thyroid ectopia or hypogenesis (author's transl)].
Fossati P; Lefèbvre J; Asfour M; Granier F; Foulinnie JC; L'Hermite M; Golstein J
Nouv Presse Med; 1977 Dec; 6(45):4177-82. PubMed ID: 416419
[TBL] [Abstract][Full Text] [Related]
12. Response of insulin, glucagon and growth hormone to arginine infusion in patients with chronic renal failure.
Marumo F; Sakai T; Sato S
Nephron; 1979; 24(2):81-4. PubMed ID: 492415
[TBL] [Abstract][Full Text] [Related]
13. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
[No Abstract] [Full Text] [Related]
14. [Behavior of basal and stimulated serum levels of prolactin, growth hormone and gonadotropins in females with chronic uremia].
Rudolf K; Rudolf H; Rüting M; Falkenhagen D
Z Gesamte Inn Med; 1988 Oct; 43(19):542-4. PubMed ID: 3145648
[TBL] [Abstract][Full Text] [Related]
15. Diminished prolactin reserve: a case report.
Spitz IM; Landau H; Almaliach U; Rosen E; Brautbar N; Russell A
J Clin Endocrinol Metab; 1977 Sep; 45(3):412-8. PubMed ID: 409726
[TBL] [Abstract][Full Text] [Related]
16. Plasma growth hormone and prolactin response to thyrotropin releasing hormone, L-dopa and luteinizing hormone-releasing hormone in alcoholic patients with liver cirrhosis.
Zanoboni A; Zanoboni-Muciaccia W; Bonfanti M; Gattei G; Zecca L
Farmaco Prat; 1980 Sep; 35(9):455-65. PubMed ID: 6778710
[No Abstract] [Full Text] [Related]
17. Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans.
Plewe G; Schneider U; Krause U; Beyer J
J Endocrinol Invest; 1987 Apr; 10(2):137-41. PubMed ID: 3035002
[TBL] [Abstract][Full Text] [Related]
18. Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.
Tolis G; Goldstein M; Friesen HG
J Clin Invest; 1973 Apr; 52(4):783-8. PubMed ID: 4632690
[TBL] [Abstract][Full Text] [Related]
19. The impact of euglycemia and hyperglycemia on stimulated pituitary hormone release in insulin-dependent diabetics.
Vierhapper H; Grubeck-Loebenstein B; Bratusch-Marrain P; Panzer S; Waldhäusl W
J Clin Endocrinol Metab; 1981 Jun; 52(6):1230-4. PubMed ID: 6785297
[TBL] [Abstract][Full Text] [Related]
20. Impaired prolactin secretion in obese patients.
Cavagnini F; Maraschini C; Pinto M; Dubini A; Polli EE
J Endocrinol Invest; 1981; 4(2):149-53. PubMed ID: 6792262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
